Proteomic patterns for early cancer detection

Drug Discovery Today

Volumn 9, Issue 20, 2004, Pages 889-897

  Veenstra, Timothy D ^a   Prieto, DaRue A ^a   Conrads, Thomas P ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

biomarkers; diagnostic medicine; Drug Discovery; OvaCheck; proteomic patterns; SELDI TOF MS

Indexed keywords

BIOLOGICAL MARKER;

BREAST CANCER; CANCER DIAGNOSIS; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; COMPUTER PROGRAM; HUMAN; INFORMATION; MAGNETISM; OVARY CANCER; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; REPRODUCIBILITY; REVIEW; SERUM; TECHNOLOGY;

HUMANS; MASS SPECTROMETRY; NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 4744350063     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03246-5     Document Type: Review

References (29)

1. Chan K.C., et al. Analysis of the human serum proteome. Clin. Prot. 1:2004;101-226
2. Anderson N.L., et al. An expanded non-redundant human plasma proteome list developed by combination of four separate sources. Mol. Cell. Proteomics. 3:2004;311-326
3. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics. 1:2002;845-867
4. Hutchens T.W., Yip T.T. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun. Mass Spectrom. 7:1993;576-580
5. Issaq H.J., et al. The surface enhanced laser desorption ionization time of flight mass spectrometric approach to diagnostic proteomics: protein profiling and biomarker detection. Anal. Chem. 75:2003;148-155
6. Weinberger S.R., et al. Current achievements using ProteinChip array technology. Curr. Opin. Chem. Biol. 6:2002;86-91
7. Izmirlian G. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann. N. Y. Acad. Sci. 1020:2004;154-174
8. Petricoin E.F., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 16:2002;572-577
9. Holland J.H. Adaptation in natural and artificial systems: an introductrory analysis with applications to biology, control, and artificial intelligence. 3rd ed:1994;155-162 MIT Press, Cambridge, Massachusetts, U. S. A.
10. Kohonen T. The self-organizing map. Proc. IEEE. 78:1990;1464-1480
11. Laronga C., et al. SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis. Markers. 19:2003;229-238
12. Qu Y., et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 48:2002;1835-1843
13. Wadsworth J.T., et al. Identification of patients with head and neck cancer using serum protein profiles. Arch. Otolaryngol. Head Neck Surg. 130:2004;98-104
14. Fels L.M., et al. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer. Dig. Dis. 21:2003;292-298
15. Rosty C., et al. Identification of hepatocarcinoma-intestine-pancreas/ pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 62:2002;1868-1875
16. Chernushevich I.V., et al. An introduction to quadrupole-time-of-flight mass spectrometry. J. Mass Spectrom. 36:2001;849-865
17. Conrads T.P., et al. High-resolution serum proteomic features for ovarian cancer detection. Endocr. Relat. Cancer. 11:2004;163-178
18. Villanueva J., et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. 15:2004;1560-1570
19. Holland E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genetics. 2:2001;120-129
20. Fishman, D.A. et al (2004). High-throughput multidimensional mass spectrometry analysis for the detection of early stage epithelial ovarian cancer: a serum test for ovarian cancer. Society of Gynecological Investigation Houston, TX, U. S. A.
21. Van Pelt C.K., et al. A fully automated nanoelectrospray tandem mass spectrometric method for analysis of Caco-2 samples. Rapid Commun. Mass Spectrom. 17:2003;1573-1578
22. Tolson J., et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab. Invest. 84:2004;845-856
23. Ye B., et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin. Cancer Res. 9:2003;2904-2911
24. Mueller W.K., et al. Serum haptoglobin in patients with ovarian malignancies. Obstet. Gynecol. 38:1971;427-435
25. Benson M.D., et al. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J. Clin. Invest. 59:1977;412-417
26. Koopmann J., et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin. Cancer Res. 10:2004;860-868
27. Petricoin E.F, Liotta L.A. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 15:2004;24-30
28. Diamandis E.P. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J. Natl. Cancer Inst. 96:2004;353-356
29. Adam B.L., et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62:2002;3609-3614